La Trobe

Therapeutically harnessing extracellular vesicles

Download (483.32 kB)
journal contribution
posted on 2025-02-26, 23:28 authored by Lesley SimLesley Sim, Andrew HillAndrew Hill
The field of extracellular vesicle (EV) research has developed rapidly over the last decade from the study of fundamental biology to a subject of significant clinical relevance. The potential of harnessing EVs in the diagnosis and treatment of diseases — including cancer and neurological and cardiovascular disorders — is now being recognized. Accordingly, the applications of EVs as therapeutic targets, biomarkers, novel drug delivery agents and standalone therapeutics are being actively explored. This Review provides a brief overview of the characteristics and physiological functions of the various classes of EV, focusing on their association with disease and emerging strategies for their therapeutic exploitation.

Funding

Research in the Hill lab is supported by grants from the National Health and Medical Research Council of Australia (to A.F.H. GNT1041413; GNT1132604), and the Australian Research Council (to A.F.H. DP170102312; DP190101655).

History

Publication Date

2022-05-01

Journal

Nature Reviews Drug Discovery

Volume

21

Pagination

379-399

Publisher

Springer Nature

ISSN

1474-1776

Rights Statement

© Springer Nature Limited 2022 This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1038/s41573-022-00410-w

Usage metrics

    Journal Articles

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC